Drug Samples Increase Healthcare Costs and Compromise Patient Safety

Researchers present a compelling case against the pharmaceutical industry's practice of providing drug samples to providers.

Related Keywords

United States ,Emily Couvillon Alagha ,Adriane Fugh Berman ,Pharmaceutical Policy ,Couvillon Alagha ,Branding ,Drug Samples ,Industry Corruption ,Marketing ,Pharmaceutical Industry ,Prescribing ,